Addex Therapeutics Ltd (SWX:ADXN)

Addex Therapeutics Statistics

Total Valuation

SWX:ADXN has a market cap or net worth of CHF 7.23 million. The enterprise value is 4.97 million.

Market Cap	7.23M
Enterprise Value	4.97M

Important Dates

The next estimated earnings date is Monday, November 10, 2025.

Earnings Date	Nov 10, 2025
Ex-Dividend Date	n/a

Share Statistics

SWX:ADXN has 111.25 million shares outstanding. The number of shares has increased by 9.98% in one year.

Current Share Class	111.25M
Shares Outstanding	111.25M
Shares Change (YoY)	+9.98%
Shares Change (QoQ)	+2.21%
Owned by Insiders (%)	23.61%
Owned by Institutions (%)	2.18%
Float	39.01M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	43.23
PB Ratio	1.00
P/TBV Ratio	1.00
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-0.82
EV / Sales	29.70
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-3.45

Financial Position

The company has a current ratio of 2.31, with a Debt / Equity ratio of 0.01.

Current Ratio	2.31
Quick Ratio	2.03
Debt / Equity	0.01
Debt / EBITDA	n/a
Debt / FCF	-0.03
Interest Coverage	-697.88

Financial Efficiency

Return on equity (ROE) is -61.91% and return on invested capital (ROIC) is -15.09%.

Return on Equity (ROE)	-61.91%
Return on Assets (ROA)	-13.55%
Return on Invested Capital (ROIC)	-15.09%
Return on Capital Employed (ROCE)	-32.72%
Revenue Per Employee	83,643
Profits Per Employee	-3.02M
Employee Count	2
Asset Turnover	0.02
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -18.33% in the last 52 weeks. The beta is 1.77, so SWX:ADXN's price volatility has been higher than the market average.

Beta (5Y)	1.77
52-Week Price Change	-18.33%
50-Day Moving Average	0.06
200-Day Moving Average	0.06
Relative Strength Index (RSI)	55.59
Average Volume (20 Days)	357,815

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, SWX:ADXN had revenue of CHF 167,285 and -6.05 million in losses. Loss per share was -0.06.

Revenue	167,285
Gross Profit	-493,098
Operating Income	-2.41M
Pretax Income	-6.15M
Net Income	-6.05M
EBITDA	-2.33M
EBIT	-2.41M
Loss Per Share	-0.06

Balance Sheet

The company has 2.30 million in cash and 38,387 in debt, giving a net cash position of 2.26 million or 0.02 per share.

Cash & Cash Equivalents	2.30M
Total Debt	38,387
Net Cash	2.26M
Net Cash Per Share	0.02
Equity (Book Value)	7.21M
Book Value Per Share	0.06
Working Capital	1.51M

Cash Flow

In the last 12 months, operating cash flow was -1.44 million and capital expenditures -1,273, giving a free cash flow of -1.44 million.

Operating Cash Flow	-1.44M
Capital Expenditures	-1,273
Free Cash Flow	-1.44M
FCF Per Share	-0.01

Margins

Gross Margin	-294.77%
Operating Margin	-1,438.85%
Pretax Margin	-3,675.87%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

SWX:ADXN does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-9.98%
Shareholder Yield	-9.98%
Earnings Yield	-83.66%
FCF Yield	-19.94%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

SWX:ADXN has an Altman Z-Score of -56.56 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-56.56
Piotroski F-Score	1